Insurance Companies

Pantheon’s Hassanally: Debut CFO unlocks secondaries for constricted investors

The manager’s $1bn CFO created access for insurance investors that had lost the ability to back PE, while offering a compelling capital raising strategy for the firm itself.

Manulife buying infra CVs, secondaries to address low DPI

Rising retail flows offer a new exit route for infra assets, but they also create their own issues, infrastructure fund investment head Kate Roscoe tells Secondaries Investor.

How we conducted Secondaries Investor’s Global Market Survey

Our inaugural survey takes the temperature of LP, GP, buyer and provider attitudes towards this fast-growing market.

Download Secondaries Investor’s Global Market Survey

Secondaries Investor’s inaugural survey of LPs, secondaries buyers, GPs and advisers offers a complete view of the market and the direction it’s heading in. Conducted in partnership with Goodwin.

Lexington leads MetLife’s $1bn managed fund deal

The insurer worked with Evercore to shop a $1.8bn portfolio under the name Project Trident, Secondaries Investor has learned.

AIG uses fund stake transfer to seed CVC $1.5bn evergreen portfolio

The pair will eye ‘additional areas of collaboration’ amid the insurer’s plans to raise its alternatives exposure.

Inside Allianz’s push into private debt secondaries, co-investments

Marc Smid, who oversees the German insurance giant’s private debt fund of funds, sets out his expectations and concerns with respect to GPs.

Private debt secondaries luring LPs across the board

Investors from German insurer Munich Re to Lithuanian family office Willgrow are jumping into the nascent asset class or considering doing so.

Why a partnership with insurer RGA is ‘strategic and accretive’ for FoxPath

Reinsurance Group of America’s investment in credit secondaries specialist FoxPath Capital Partners will broaden its access to private assets.

StepStone emerges as buyer for Taiwan Life’s PE portfolio sale

The deal marks another notable transaction by a Taiwanese insurer following Fubon Life’s over $1bn sale of a private market portfolio.